1. P-291The DISTINCTIVE study: A biologically enriched phase II study of seconD-line folfiri/aflIbercept in proSpecTIvely stratified, anti-EGFR resistaNt, metastatic coloreCTal cancer patIents with RAS Validated wild typE status - Trial in progress. (20th June 2018) Authors: Ziranu, P; Demurtas, L; Puzzoni, M; Loupakis, F; Daniele, B; Rimassa, L; Bilancia, D; Lonardi, S; Avallone, A; Pella, N; Ferrari, D; Frassineti, L; Beretta, G; Zaniboni, A; Santoro, A; Zampino, M; Sarobba, M; Zagonel, V; Barni, S; Palmieri, G Journal: Annals of oncology Issue: Volume 29(2018)Supplement 5 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. 522PPrognostic value of neutrophil-lymphocite ratio in resected high risk colorectal cancer: An analysis of adjuvant TOSCA trial. (23rd October 2018) Authors: Petrelli, F; Rosati, G; Banzi, M; Zampino, M G; Pella, N; Di Bartolomeo, M; Maiello, E; Bidoli, P; Ferrari, D; Rimassa, L; Labianca, R; Scartozzi, M; Lonardi, S; de Placido, S; Zaniboni, A; Sobrero, A; Frassineti, L G; Silvestris, N; Corsi, D; Galli, F Journal: Annals of oncology Issue: Volume 29(2018)Supplement 8 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. 583PThromboembolic risk and survival with Khorana score in resected colorectal cancer patients: Subgroup analysis from the adjuvant TOSCA trial. (23rd October 2018) Authors: Barni, S; Rosati, G; Zagonel, V; Pella, N; Banzi, M; Zampino, M G; Di Bartolomeo, M; Rimassa, L; Marchetti, P; Maiello, E; Artioli, F; Ferrari, D; Labianca, R; Bidoli, P; Zaniboni, A; Sobrero, A; Iaffaioli, V; de Placido, S; Frassineti, L G; Galli, F Journal: Annals of oncology Issue: Volume 29(2018)Supplement 8 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. The hard road to data interpretation: 3 or 6 months of adjuvant chemotherapy for patients with stage III colon cancer?. (9th February 2018) Authors: Sobrero, A; Grothey, A; Iveson, T; Labianca, R; Yoshino, T; Taieb, J; Maughan, T; Buyse, M; André, T; Meyerhardt, J; Shields, A F; Souglakos, I; Douillard, J -Y; Cervantes, A Journal: Annals of oncology Issue: Volume 29:Number 5(2018) Page Start: 1099 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. Fluorouracil and dose-dense adjuvant chemotherapy in patients with early-stage breast cancer (GIM2): end-of-study results from a randomised, phase 3 trial. Issue 12 (December 2022) Authors: Del Mastro, Lucia; Poggio, Francesca; Blondeaux, Eva; De Placido, Sabino; Giuliano, Mario; Forestieri, Valeria; De Laurentiis, Michelino; Gravina, Adriano; Bisagni, Giancarlo; Rimanti, Anita; Turletti, Anna; Nisticò, Cecilia; Vaccaro, Angela; Cognetti, Francesco; Fabi, Alessandra; Gasparro, Simon... Journal: Lancet oncology Issue: Volume 23:Issue 12(2022) Page Start: 1571 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. Impact of recent legislative bills regarding clinical research on Italian ethics committee activity. Issue 10 (30th September 2008) Authors: Porcu, L; Poli, D; Torri, V; Rulli, E; Di Tullio, M C; Cinquini, M; Bajetta, E; Labianca, R; Di Costanzo, F; Nitti, D; Floriani, I Journal: Journal of medical ethics Issue: Volume 34:Issue 10(2008) Page Start: 747 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗